Lewis Darrell R, Price Marianne O, Feng Matthew T, Price Francis W
*Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada; †Cornea Research Foundation of America, Indianapolis, IN; and ‡Price Vision Group, Indianapolis, IN.
Cornea. 2017 Oct;36(10):1227-1232. doi: 10.1097/ICO.0000000000001303.
To describe the recurrence of granular corneal dystrophy type 1 (GCD1) after penetrating keratoplasty (PKP), anterior lamellar keratoplasty (ALK), deep anterior lamellar keratoplasty (DALK), and phototherapeutic keratectomy (PTK) in a single population. The time required to achieve best-corrected visual acuity (BCVA) after each intervention was also analyzed.
Retrospective review of all patients with GCD1 from a single center between 1989 and 2016. Surgical interventions were performed 50 times on 28 eyes of 15 patients. Data were primarily analyzed through Cox regression modeling with clustering and robust log-rank testing.
Significant recurrence occurred most rapidly after PTK (median time 2.7 years) and was most delayed after PKP (13.7 years). Significant recurrence occurred at a similar interval after ALK and DALK (3.7 and 3.2 years, respectively). Significant recurrence-free survival was longer for PKP than for ALK, DALK, or PTK (P = 0.04). The time required to obtain BCVA was shorter in the PTK group (median 1.8 months) than in the PKP and DALK groups (median 5.3 and 8.4 months, respectively; P = 0.03 and P = 0.02). All groups achieved a similar median BCVA (20/25-20/30).
This series indicates that GCD1 recurrence-free survival is longest after PKP with an associated delay in attaining BCVA. Conversely, PTK provided the fastest visual recovery with shorter recurrence-free survival.
描述在同一人群中穿透性角膜移植术(PKP)、前板层角膜移植术(ALK)、深板层角膜移植术(DALK)和光治疗性角膜切除术(PTK)后颗粒状角膜营养不良1型(GCD1)的复发情况。同时分析每次干预后达到最佳矫正视力(BCVA)所需的时间。
回顾性分析1989年至2016年来自单一中心的所有GCD1患者。对15例患者的28只眼进行了50次手术干预。数据主要通过具有聚类和稳健对数秩检验的Cox回归模型进行分析。
PTK后GCD1复发最快(中位时间2.7年),PKP后复发最延迟(13.7年)。ALK和DALK后显著复发的间隔时间相似(分别为3.7年和3.2年)。PKP的无显著复发生存期比ALK、DALK或PTK更长(P = 0.04)。PTK组获得BCVA所需时间比PKP和DALK组短(中位时间分别为1.8个月、5.3个月和8.4个月;P = 0.03和P = 0.02)。所有组的BCVA中位数相似(20/25 - 20/30)。
本系列研究表明,PKP后GCD1的无复发生存期最长,但达到BCVA会延迟。相反,PTK视觉恢复最快,但无复发生存期较短。